During the past decade, Panthera Biopartners - Manchester conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Panthera Biopartners - Manchester" are "Migraine" (1 trials) and "NASH - Nonalcoholic Steatohepatitis" (1 trials). Many other conditions were trialed in "Panthera Biopartners - Manchester" in a lesser frequency.

Most popular intervention types in "Panthera Biopartners - Manchester" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Eptinezumab" (1 trials) and "IVA337" (1 trials). Other intervention names were less common.

The vast majority of trials in "Panthera Biopartners - Manchester" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Panthera Biopartners - Manchester". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Panthera Biopartners - Manchester, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Panthera Biopartners - Manchester, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".